Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kati Hurst"'
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 33:50-51
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 33:50-51
Autor:
Ana Isabel Heiniger Mazo, Manuel Espeso de Haro, Maria Cristina Moragues Martinez, Kati Hurst, Manuel Barrios Garcia
Publikováno v:
Blood. 124:5459-5459
BACKGROUND: Primary mediastinal B-cell lymphoma (PMBCL) are a subtype of diffuse large B cell lymphoma (DLBCL), that represent 2-4% of all non-Hodgkin lymphoma (NHL) and 6-12% of DLBCL. They affect young adults with a median age at diagnosis of 35 ye
Autor:
Maria Cristina Moragues Martinez, Kati Hurst, Ana Isabel Heiniger Mazo, Maria Eva Mingot Castellano
Publikováno v:
Blood. 124:4196-4196
Introduction: Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by accelerated platelet destruction and inadequate platelet production mediated by autoantibodies. As there are no specific diagnostic tests, the diag
Autor:
Jose Coin Ruiz, Maria Elisa Prieto Sanchez, Manuel Espeso de Haro, Kati Hurst, Maria Cristina Moragues Martinez, Maria Dolores Bautista Ojeda, Ana Isabel Heiniger Mazo, Macarena Ortiz Pareja, Maria Eva Mingot Castellano, Isabel Vidales Mancha
Publikováno v:
Blood. 122:4757-4757
Introduction Splenectomy is a diagnostic tool and an option of treatment for some diseases. After splenectomy, the risk of infection is not clear in adult populations, therefore designing and implementing the best prevention and management strategys
Autor:
Kati Hurst, Alicia Bailén Garcia, Concepción Bethencourt Mateos, Eva Mingot Castellano, Patricia Ainhoa Fuentes Galvez, Ana Isabel Heiniger Mazo
Publikováno v:
Blood. 120:4407-4407
Abstract 4407 Introduction: The treatment of acquired aplastic anemia (AA) is based on allogeneic hematopoietic cell transplantation (HCT) and immunosuppressive therapy (IST). The choice between immunosuppression or HCT is based on the availability o